NeurAxis, Inc. (AMEX:NRXS) Q4 2025 Earnings Call Transcript March 19, 2026 Operator: Ladies and gentlemen, thank you for standing by. Welcome to the NeurAxis, Inc. fourth quarter 2025 financial ...

Conference call will be held today, Thursday, March 19 at 9:00 am ETCARMEL, Ind., March 19, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical ...

This workshop is designed to give nephrology teams the confidence they need to navigate complex regulatory requirements ...

NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic ...

The U.S. FDA granted marketing authorization for ProSense in October 2025 for use in low-risk early-stage breast cancer, specifically for women aged 70 and over or those unsuitable for surgery. Market ...

IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive ...

There’s a moment every psychiatrist recognizes. A patient sits down. You have 20 minutes. But their life is not 20 minutes wide.

IceCure Medical Ltd (NASDAQ:ICCM) Q4 2025 Earnings Call Transcript March 17, 2026 IceCure Medical Ltd misses on earnings expectations. Reported EPS is $-0.06 EPS, expectations were $-0.05. Operator: ...

Prohealth Business Solutions Pvt Ltd, a Noida-based healthcare services company supporting hospitals and physician practices across the United States, has been honoured with the India 5000 Best MSME ...

Record 4th quarter and full year sales of $1.3 million and $3.4 million, respectively Strong commercial momentum for ProSense® in the U.S. and globally following FDA ...

The American College of Cardiology, American Heart Association and nine other medical associations March 13 released updated ...